Sharps Technology Appoints Justin Page as Vice President of 9-02-2023, 21:25

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Acronis Introduces Advanced Automation to Simplify MSP Business Operations for Enhanced Productivity 14-09-2023, 19:01